TY - JOUR AU - Garbe, Claus AU - Amaral, Teresa AU - Peris, Ketty AU - Hauschild, Axel AU - Arenberger, Petr AU - Basset-Seguin, Nicole AU - Bastholt, Lars AU - Bataille, Veronique AU - Del Marmol, Veronique AU - Dréno, Brigitte AU - Fargnoli, Maria C AU - Forsea, Ana-Maria AU - Grob, Jean-Jacques AU - Hoeller, Christoph AU - Kaufmann, Roland AU - Kelleners-Smeets, Nicole AU - Lallas, Aimilios AU - Lebbé, Celeste AU - Lytvynenko, Bodhan AU - Malvehy, Josep AU - Moreno-Ramirez, David AU - Nathan, Paul AU - Pellacani, Giovanni AU - Saiag, Philippe AU - Stratigos, Alexander J AU - Van Akkooi, Alexander C J AU - Vieira, Ricardo AU - Zalaudek, Iris AU - Lorigan, Paul AU - European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO), and the European Organization for Research and Treatment of Cancer (EORTC) PY - 2022 DO - 10.1016/j.ejca.2022.04.018 UR - http://hdl.handle.net/10668/22176 T2 - European journal of cancer (Oxford, England : 1990) AB - A unique collaboration of multidisciplinary experts from the European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO), and the European Organization of Research and Treatment of Cancer (EORTC) was formed to make... LA - en KW - Adjuvant treatment KW - Cutaneous melanoma KW - Excisional margins KW - Interferon-α KW - Metastasectomy KW - Sentinel lymph node dissection KW - Systemic treatment KW - Tumor thickness KW - Antineoplastic Combined Chemotherapy Protocols KW - Consensus KW - Humans KW - Melanoma KW - Mutation KW - Neoplasm Staging KW - Oximes KW - Proto-Oncogene Proteins B-raf KW - Skin Neoplasms KW - Systematic Reviews as Topic TI - European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022. TY - research article VL - 170 ER -